BDR Pharmaceuticals International Private Limited — Everolimus Exporter Profile
Indian Pharmaceutical Exporter · #4 for Everolimus · $750.0K export value · DGFT Verified
BDR Pharmaceuticals International Private Limited is the #4 Indian exporter of Everolimus with $750.0K in export value and 15 verified shipments. BDR Pharmaceuticals International Private Limited holds a 2.0% market share in Everolimus exports across 8 countries. The company exports 12 pharmaceutical products worth $4.4M across 3 therapeutic categories.
BDR Pharmaceuticals International Private Limited — Everolimus Export Profile: Buyers & Destinations
Where Does BDR Pharmaceuticals International Private Limited Export Everolimus?
| Country | Value | Shipments | Share |
|---|---|---|---|
| DOMINICAN REPULIC | $68.8K | 2 | 29.1% |
| PERU | $50.0K | 2 | 21.1% |
| MALAYSIA | $50.0K | 2 | 21.1% |
| SRI LANKA | $33.4K | 1 | 14.1% |
| KENYA | $31.5K | 3 | 13.3% |
| NEPAL | $2.5K | 2 | 1.1% |
| UGANDA | $524 | 1 | 0.2% |
| ALGERIA | $2 | 2 | 0.0% |
BDR Pharmaceuticals International Private Limited exports Everolimus to 8 countries. The largest destination is DOMINICAN REPULIC accounting for 29.1% of BDR Pharmaceuticals International Private Limited's Everolimus shipments, followed by PERU (21.1%) and MALAYSIA (21.1%). These destinations reflect BDR Pharmaceuticals International Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Everolimus from BDR Pharmaceuticals International Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| FRISA | DOMINICAN REPULIC | $68.8K | 2 |
| DISDROSA, | PERU | $50.0K | 2 |
| SUNIME LIMITED | MALAYSIA | $50.0K | 2 |
| PHARASS | SRI LANKA | $33.4K | 1 |
| RIPHALT | KENYA | $31.5K | 3 |
| TANEPVLT | NEPAL | $2.5K | 2 |
| ONCOLT | UGANDA | $524 | 1 |
BDR Pharmaceuticals International Private Limited supplies Everolimus to 7 buyers globally. The largest buyer is FRISA (DOMINICAN REPULIC), followed by DISDROSA, (PERU) and SUNIME LIMITED (MALAYSIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Everolimus Export Value and How Much Does BDR Pharmaceuticals International Private Limited Contribute?
India exported $17.9M worth of Everolimus through 620 shipments from 87 suppliers to 67 countries, serving 135 buyers globally. BDR Pharmaceuticals International Private Limited contributes $750.0K to this total, accounting for 2.0% of India's Everolimus exports. BDR Pharmaceuticals International Private Limited ships Everolimus to 8 countries through 7 buyers.
What Is the Average Shipment Value for BDR Pharmaceuticals International Private Limited's Everolimus Exports?
BDR Pharmaceuticals International Private Limited's average Everolimus shipment value is $50.0K per consignment, based on 15 shipments totaling $750.0K. The largest destination is DOMINICAN REPULIC (29.1% of BDR Pharmaceuticals International Private Limited's Everolimus exports).
How Does BDR Pharmaceuticals International Private Limited Compare to Other Indian Everolimus Exporters?
BDR Pharmaceuticals International Private Limited ranks #4 among 87 Indian Everolimus exporters with a 2.0% market share. The top 3 exporters are NATCO PHARMA LIMITED ($11.2M), ALKEM LABORATORIES LIMITED ($4.8M), BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED ($750.0K). BDR Pharmaceuticals International Private Limited processed 15 shipments to 8 destination countries.
What Everolimus Formulations Does BDR Pharmaceuticals International Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| EVEROLIMUS 10MG TAB (1X10S TAB STRIPS) | $50.0K | 1 |
| EVEROLIMUS TABLETS 0.75MG(FORPANIL TABLE | $50.0K | 1 |
| EVEROLIMUS GRANULES 3.33% W/W OTHER TAX DOCUMENT MH1160000396 DTD. 28.11.2023 | $50.0K | 1 |
| EVEROLIMUS TABLETS 0 25MG 1X10S TABSSSTRIP TAX INV NO GST 206 22 23 DTD 22 07 2022 | $33.4K | 1 |
| EVEROLIMUS 5MG TAB (1X10S TAB STRIPS)(L | $18.8K | 1 |
| EVEROLIMUS TAB 10MG EVERBLISS OTHER TAX INV MH2511600060 DT 10 05 2025 | $15.6K | 1 |
| EVEROLIMUS TAB 10 MG(EVERBLISS) (OTHER)(TAX INVMH1160000413 DT05.12.2023) | $8.0K | 1 |
| EVEROLIMUS TAB 10 MGEVERBLISS OTHER | $7.9K | 1 |
| EVEROLIMUS TAB 5MG EVERBLISS 5MG 1X10TABS STRIPS 1X10 TABS STRIPS | $1.6K | 1 |
| EVEROLIMUS TAB 5MG(EVERBLISS 5MG)(1x10 T | $851 | 1 |
BDR Pharmaceuticals International Private Limited exports 14 distinct Everolimus formulations including tablets, capsules, syrups, and combination drugs. The top formulation is EVEROLIMUS 10MG TAB (1X10S TAB STRIPS) with 1 shipments worth $50.0K.
How Does BDR Pharmaceuticals International Private Limited Compare to Nearest Everolimus Exporters?
Exporters ranked immediately above and below #4 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | NATCO PHARMA LIMITED | $11.2M | 223 | 8 | $50.0K |
| 2 | ALKEM LABORATORIES LIMITED | $4.8M | 95 | 4 | $50.0K |
| 4 | BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED ★ | $750.0K | 15 | 8 | $50.0K |
| 6 | ALKEM LABORATORIES LTD | $464.8K | 17 | 2 | $27.3K |
| 3 | BIOCON PHARMA LIMITED | $250.0K | 5 | 1 | $50.0K |
BDR Pharmaceuticals International Private Limited ranks #4 among 87 Indian Everolimus exporters. Average shipment value of $50.0K compared to the market average of $205.9K. The closest competitors by value are NATCO PHARMA LIMITED and ALKEM LABORATORIES LIMITED.
Which Indian Ports Ship Everolimus Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 91 | 14.7% |
| HYDERABAD AIR | 91 | 14.7% |
| SAHAR AIR | 79 | 12.7% |
| HYDERABAD ACC (INHYD4) | 61 | 9.8% |
| DELHI AIR | 43 | 6.9% |
| NHAVA SHEVA SEA (INNSA1) | 29 | 4.7% |
| ACC SHAMSHABAD AIRPO | 23 | 3.7% |
| Bombay Air | 20 | 3.2% |
About BDR Pharmaceuticals International Private Limited
BDR Pharmaceuticals International Private Limited exports 12 products worth $4.4M. Beyond Everolimus, top products include Tamoxifen, Lapatinib, Capecitabine, Thalidomide, Amphotericin. View the complete BDR Pharmaceuticals International Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Everolimus — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Everolimus shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: BDR Pharmaceuticals International Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 15 individual customs records matching BDR Pharmaceuticals International Private Limited exporting Everolimus, covering 14 formulations to 8 countries via 7 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 67+ countries, 135+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Everolimus Export Data from BDR Pharmaceuticals International Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for BDR Pharmaceuticals International Private Limited's Everolimus exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
BDR Pharmaceuticals International Private Limited
Full Company Profile →
12 products · $4.4M total trade · 3 categories
Everolimus Stats
Company Overview
Top Products by BDR Pharmaceuticals International Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for BDR Pharmaceuticals International Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Everolimus. For current shipment-level data, contact TransData Nexus.